<?xml version="1.0" encoding="UTF-8"?>
<p id="Par39">The second major pathway implicated in PD pathogenesis is mitochondrial metabolism, which is susceptible to damage by oxidative stress. A prevailing hypothesis is that mutations in 
 <italic>PRKN</italic> and 
 <italic>PINK1</italic> cause PD due to mitochondrial dysfunction. Clinically, people with PRKN PD and PINK1 PD display an earlier-onset, are sensitive to levodopa, and are prone to motor fluctuations. And, Â these patients have minimal cognitive decline, even after many years of disease [
 <xref ref-type="bibr" rid="CR13">13</xref>].
</p>
